Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (71-80 of 270) with videos related to

Pageof 27
Sort By:
Cancer Cell|January 30, 2004
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)Clara Tan, Severine Cruet-Hennequart, Armelle Troussard, et al.
Cancer Research|June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancerBoris A Hadaschik, Kaixin Zhang, Alan I So, et al.
Cancer Research|May 19, 2007
DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cellsJ Erin Tillman, Jialing Yuan, Guangyu Gu, et al.
Molecular Endocrinology (Baltimore, Md.)|August 8, 2014
Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancerYingqiu Xie, Wenfu Lu, Shenji Liu, et al.
Molecular Cancer Therapeutics|February 7, 2015
Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell CarcinomaKyung Seok Han, Na Li, Peter A Raven, et al.
Molecular Cancer Therapeutics|March 6, 2015
Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and ChemotherapyBarbara Lelj-Garolla, Masafumi Kumano, Eliana Beraldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.
Oncotarget|January 23, 2014
GATA2 as a potential metastasis-driving gene in prostate cancerYan Ting Chiang, Kendric Wang, Ladan Fazli, et al.
Plos One|March 26, 2014
Prostate stromal cells express the progesterone receptor to control cancer cell mobilityYue Yu, Jennifer Suehyun Lee, Ning Xie, et al.
Plos One|February 15, 2013
BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cellsChristopher G Low, Iris S U Luk, Dong Lin, et al.
Pageof 27

Showing results (71-80 of 270) with videos related to

Sort By:
Pageof 27
Cancer Cell|January 30, 2004
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)Clara Tan, Severine Cruet-Hennequart, Armelle Troussard, et al.
Cancer Research|June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancerBoris A Hadaschik, Kaixin Zhang, Alan I So, et al.
Cancer Research|May 19, 2007
DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cellsJ Erin Tillman, Jialing Yuan, Guangyu Gu, et al.
Molecular Endocrinology (Baltimore, Md.)|August 8, 2014
Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancerYingqiu Xie, Wenfu Lu, Shenji Liu, et al.
Molecular Cancer Therapeutics|February 7, 2015
Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell CarcinomaKyung Seok Han, Na Li, Peter A Raven, et al.
Molecular Cancer Therapeutics|March 6, 2015
Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and ChemotherapyBarbara Lelj-Garolla, Masafumi Kumano, Eliana Beraldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.
Oncotarget|January 23, 2014
GATA2 as a potential metastasis-driving gene in prostate cancerYan Ting Chiang, Kendric Wang, Ladan Fazli, et al.
Plos One|March 26, 2014
Prostate stromal cells express the progesterone receptor to control cancer cell mobilityYue Yu, Jennifer Suehyun Lee, Ning Xie, et al.
Plos One|February 15, 2013
BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cellsChristopher G Low, Iris S U Luk, Dong Lin, et al.
Pageof 27